REVOLUTIONIZING HEALTHCARE DIAGNOSTICS: FIRST AI BLOOD TEST RESULTS – INTERPRETATION SOFTWARE WITH EU-MDR CERTIFICATION

  Smart Blood Analytics Swiss, a pioneering leader in healthcare technology in the segment of blood test result interpretation, proudly announces that its groundbreaking product, SBAS Software, achieved the first EU-MDR (European Medical Device Regulation) certification1 as a medical device using cutting-edge AI technology for blood test result interpretation. Based on the European Database of […]

Continue Reading

NARCX+ FIRST TO MEET DEA STANDARDS FOR DESTROYING ILLICIT FENTANYL AND RENDERING IT NON-RETRIEVABLE

NarcX Solutions, Inc., a Utah-based company and rapidly rising innovator for on-site drug disposal, announces a major milestone in the fight against Illicit Fentanyl. Independent Lab Validation and Patent Proving Disruptive in War on Illicit Fentanyl NarcX+ has successfully completed the first independent validation, by a 3rd party criminal laboratory, of its kind by testing […]

Continue Reading

CAPITAL ON TAP INTRODUCES REVOLUTIONARY PRELOADING FEATURE TO EXTEND SME SPENDING POWER

Capital on Tap, a global FinTech providing an all-in-one business credit card and spend management platform, today introduced Preloading. This first-of-its-kind functionality allows customers to extend their spending capabilities beyond their existing credit limit. Capital on Tap launches Preloading, a powerful feature allowing customers to top up their Capital on Tap credit balance with their […]

Continue Reading

KELKOO GROUP COMMENTS ON ADVOCATE GENERAL KOKOTT’S OPINION ABOUT GOOGLE’S LAST DITCH APPEAL AGAINST 2017 €2.42BN SHOPPING FINE

Rich Stables CEO of Kelkoo Group comments: “Advocate General Kokott’s opinion that the Court of Justice should dismiss Google’s appeal and confirm the €2.42bn fine adds to the tide of opinion against Google’s conduct in Shopping. We are delighted that the opinion verifies that the European Commission correctly found that Google self-preferenced its own services to the […]

Continue Reading

CAPITAL ON TAP ANNOUNCES LEADERSHIP EVOLUTION: DAVID LUCK TO ASSUME ROLE OF EXECUTIVE CHAIRMAN, DAMIAN BRYCHCY AS CEO

In a move marking a new chapter in its growth story, Capital on Tap, one of Europe’s fastest-growing businesses, today announced a strategic leadership transition. Co-founder David Luck is set to embrace the role of Executive Chairman, entrusting the CEO mantle to Damian Brychcy, the company’s Chief Product Officer. “Guiding Capital on Tap for over ten […]

Continue Reading

WINTERMUTE BIOMEDICAL RECEIVES ETHICS APPROVAL FOR PHASE IB CLINICAL TRIAL OF SOLEXAN IN SHINGLES PATIENTS

Breaking Ground in Shingles Treatment: Wintermute Biomedical Advances to Clinical Trials … Wintermute Biomedical is excited to report that in December 2023 they have received full approval to conduct a Phase IB clinical trial in Australia using their first-in-class topical antiviral, Solexan. Solexan has been developed over the last 12 years by Wintermute Biomedical as a […]

Continue Reading

MOST UK BUSINESSES UNPREPARED FOR ENERGY DISRUPTION DESPITE GROWING INTEREST IN SUSTAINABLE ENERGY SOLUTIONS

Critical Power Supplies Survey Sheds Light on a Major Concern – Just 13% of business currently have net zero transitional plan in place. More than half of organisations are unprepared for future energy shortages or disruptions despite more than two-thirds agreeing that demand for back-up power generation is set to rise, according to new data […]

Continue Reading